Microscopic polyangiitis associated with marked systemic bleeding tendency caused by disseminated intravascular coagulation

Internal Medicine

Volumn 42, Issue 9, 2003, Pages 850-855

  Saito, Takatoshi ^a   Tsuchiya, Masahito ^a   Shikata, Chihiro ^a   Yamaguchi, Hiroshi ^a   Miyata, Shu Ichi ^a   Matsuo, Sei Ichiro ^a   Ishizawa, Sho ^a   Yoshimura, Kunihiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti neutrophil cytoplasmic antibody; Gabexate mesilate; Pulmonary hemorrhage; Rapidly progressive pulmonary failure

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; D DIMER; FIBRIN DEGRADATION PRODUCT; GABEXATE MESILATE; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PLASMIN INHIBITOR; PREDNISOLONE; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY DETECTION; ARTICLE; BLEEDING TENDENCY; BRAIN HEMORRHAGE; CASE REPORT; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; DRUG EFFICACY; DRUG PULSE THERAPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; INFECTION; KIDNEY FAILURE; LUNG HEMORRHAGE; MICROVASCULATURE; PLASMAPHERESIS; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; VASCULITIS;

EID: 0141961854     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.850     Document Type: Article

References (23)

1. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 337: 1512-1523, 1997.
2. Harper L, Savage CO. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol 190: 349-359, 2000.
3. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87: 4115-4119, 1990.
4. Bratt J, Palmblad J. Cytokine-induced neutrophil-mediated injury of human endothelial cells. J Immunol 159: 912-918, 1997.
5. Kaplanski G, Fabrigoule M, Boulay V, et al. Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-α-independent IL-8 secretion and E-selectin expression. J Immunol 158: 5435-5441 1997.
6. Johnson K, Choi Y, DeGroot E, Samuels I, Creasey A, Aarden L. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 160: 5130-5135, 1998.
7. Souter PJ, Thomas S, Hubbard AR, Poole S, Romisch J, Gray E. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med 29: 134-139, 2001.
8. Kumakura S, Ishikura H, Umegae N, Yamagata S, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Am J Med 102: 113-115, 1997.
9. Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86: 3189-3195, 1995.
10. Kallenberg CG, Tervaert JW, van der Woude FJ, Goldschmeding R, von dem Borne AE, Weening JJ. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? Immunol Today 12: 61-64, 1991.
11. Barnett CC, Moore EE, Mierau GW, et al. ICAM-1-CD18 interaction mediates neutrophil cytotoxicity through protease release. Am J Physiol 274: C1634-1644, 1998.
12. Vargunam M, Adu D, Taylor CM, et al. Endothelium myeloperoxidase-antimyeloperoxidase interaction in vasculitis. Nephrol Dial Transplant 7: 1077-1081, 1995.
13. Esmon CT, Fukudome K, Mather T, et al. Inflammation, sepsis, and coagulation. Haematologica 84: 254-259, 1999.
14. Kallenberg CG. Autoantibodies to myeloperoxidase: clinical and pathophysiological significance. J Mol Med 76: 682-687, 1998.
15. Endo Y, Terada M, Ohdaira T, Haraguchi M. An autopsy case of Good-pasture's syndrome with P-ANCA and systemic vasculitis. Nihon Kokyuki Gakkai Zasshi 37: 55-60, 1999 (Abstract in English).
16. van Gorp EC, Suharti C, ten Cate H, et al. Review: infectious diseases and coagulation disorder. J Infect Dis 180: 176-186, 1999.
17. Hergesell O, Andrassy K, Nawroth P. Elevated levels of markers of endothelail cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis. Thrombo Haemost 75: 892-898, 1996.
18. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 91: 1-12, 1993.
19. Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Ueno C, Matsumoto A. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocyte. Shock 15: 101-105, 2001.
20. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Sekine I. Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury. J Leukoc Biol 69: 241-247, 2001.
21. Umeki S, Adachi M, Watanabe M, Yaji S, Soejima R. Gabexate as a therapy for disseminated intravascular coagulation. Arch Intern Med 148: 1409-1412, 1988.
22. Aosasa S, Ono S, Seki S, et al. Inhibitory effect of protease inhibitor on endothelial cell activation. J Surg Res 80: 182-187, 1998.
23. Murakami K, Okajima K, Uchida M, Okabe H, Takatsuki K. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocyte. Crit Care Med 24: 1047-1053, 1996.